CMV pp65 (495-503) HLA-A*02:01 NLVPMVATV
Sipariş numarası: P2296.9501
Shipping: Shipment: not cooled. Store at -20°C. For laboratory usage only!Teslim süresi yaklaşık. 5 iş günü
| Miktar | Birim fiyatı |
|---|---|
| Hedef 2 | 145,00 € * |
| Kaynak 3 | 116,00 € * |
Fiyatlar artı KDV artı nakliye maliyetleri
Single peptide (NLVPMVATV) for stimulation of human CMV specific CD8+ T-cells.
The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. Purities offered: >95%.
T-cell epitopes are presented on the surface of antigen-presenting cells by MHC molecules. T cell epitopes presented by MHC class I molecules are typically peptides between 8 and 11 amino acids in length and exhibiting MHC-specific sequence motifs.
Technische Daten:
Specifications:
Purity: >95% (HPLC, ESi-MS)
Sequence: NLVPMVATV (H-Asn-Leu-Val-Pro-Met-Val-Ala-Thr-Val-OH)
MW = 943.2 g/mol
HLA-Type: HLA-A*02:01
lyophilized powder
Applikation:
T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune responseQuelle
syntheticSicherheits Hinweise / Safety
Klassifizierungen / Classification
eclass-Nr: 32-16-04-09Dokumente - Protokolle - Downloads
Hier finden Sie Informationen und weiterführende Literatur zu CMV pp65 (495-503) HLA-A*02:01 NLVPMVATV. Für weitere Dokumente (Zertifikate mit weiteren Lotnummern, Sicherheitsdatenblätter in anderer Sprache, weitere Produktinformationen) wenden Sie sich bitte an Genaxxon biosience unter: info@genaxxon.com oder Tel.: +49 731 3608 123.
